Alcohol withdrawal changes cardiovascular responses to propranolol challenge

Neuropsychobiology

Volumn 47, Issue 4, 2003, Pages 192-197

  Kähkönen, Seppo ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alcohol withdrawal; Blood pressure; Cardiac output; Heart rate; Propranolol

Indexed keywords

PROPRANOLOL;

ADRENERGIC SYSTEM; ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ARTICLE; BIOAVAILABILITY; BRADYCARDIA; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INOTROPISM; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RECEPTOR SENSITIVITY; SYMPATHETIC TONE; WITHDRAWAL SYNDROME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CARDIAC OUTPUT; ETHANOL; HEART RATE; HUMANS; MALE; PROPRANOLOL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037671495     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071214     Document Type: Article

References (32)

1. Gross MM, Lewis E, Hastey J: Acute alcohol withdrawal syndrome; in Kissen B, Begleiter H (eds): Biology of Alcoholism. Clinical Pathology. New York, Plenum Press, 1974, vol 3, pp 191-263.
2. Koch-Weser J, Sellers EM, Kalant H: Alcohol intoxication and withdrawal. N Engl J Med 1976;294:757-762.
3. Carlsson C: Haemodynamic studies in alcoholics in the withdrawal phase. Int J Clin Pharmacol Ther Toxicol 1971;3:61-63.
4. Beckman H, Frank RR, Robertson RD, Brady KA, Coin EJ: Evaluation of blood pressure during early alcohol withdrawal. Ann Emerg Med 1981;10:32-35.
5. Saunders JB, Beevers DG, Paton A: Alcohol-induced hypertension. Lancet 1981;ii:653-656.
6. Clark LT, Friedman HS: Hypertension associated with alcohol withdrawal: Assessment of mechanisms and complications. Alcohol Clin Exp Res 1985;9:125-130.
7. Kähkönen S, Bondarenko BB: Cardiovascular changes in alcohol patients during withdrawal phase. German J Psychiatry 2000;3:1-6.
8. King AC, Errico AL, Parsons OA: Blood pressure dysregulation associated with alcohol withdrawal. Alcohol Clin Exp Res 1991;15:478-482.
9. Potter JF, Bannan LT, Beevers DG: Alcohol and hypertension. Br J Addict 1984;79:365-373.
10. Potter JF, Bannan LT, Beevers DG: The effect of a non-selective lipophilic beta-blocker on the blood pressure and noradrenaline, vasopressin, corticol and renin release during alcohol withdrawal. Clin Exp Hypertens A 1984;6:1147-1160.
11. Zilm DH, Jacob MS, MacLeod SM, Sellers EM, Ti TY: Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcohol Clin Exp Res 1980;4:400-405.
12. Worner TM: Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: Double-blind controlled trial. Am J Drug Alcohol Abuse 1994;20:115-124.
13. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, American Psychiatric Association, 1980, pp 169-170.
14. Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH: Development and evaluation of an impedance cardiac output system. Aerosp Med 1966;37:1208-1212.
15. Pushkar YT, Bolshov VM, Yelisarova NA: Determination of the cardiac output by impedance cardiography (in Russian). Cardiology 1977;17:85-90.
16. Sherwood A, Allen MT, Fahrenberg J, Kelsey RM, Lovallo WR, van Doornen LJP: Methodological guidelines for impedance cardiography. Psychophysiology 1990:27:1-23.
17. Fuller HG: The validity of cardiac output measurement by thoracic impedance: A meta-analysis. Clin Invest Med 1992;15:103-112.
18. Gundarov IA, Pushkar YT, Konstantinov YI: The central hemodynamic norms determined by impedance cardiography (in Russian). Ther Arch 1983;55:26-28.
19. Hänninen U: Determination of propranolol in human plasma by high-performance liquid chromatography. Espoo, Internal Report Orion Corporation Ltd, 1987.
20. Sellers EM, Degani NC, Zilm DH, Macleod SM: Propranolol-decreased noradrenaline excretion and alcohol withdrawal. Lancet 1976;ii:94-95.
21. Mendelson JH: Biological concomitants of alcoholism. N Engl J Med 1970;283:24-32.
22. Segal LD, Mason DT: β-Adrenergic receptors in chronic alcoholic rat hearts. Cardiovasc Res 1982;16:34-39.
23. Banerjee SP, Sharma VK, Khanna JM: Alterations in β-adrenergic receptor binding during ethanol withdrawal. Nature 1978;276:407-409.
24. Hoffman PL, Valverius P, Kwast M, Tabakoff B: Comparison of the effects of ethanol on β-adrenergic receptors in heart and brain. Alcohol Alcohol 1987;11:749-754.
25. Bylund DB, Solomon N, Ray-Prenger C, Jones SB, Harris RA: Comparison of adrenergic receptor binding in blood cells from alcoholics and controls. Alcohol 1984;1:369-372.
26. Kuriyama K, Muramatsu M, Aiso M, Ueno E: Alteration in β-adrenergic receptor binding in brain, lung and heart during morphine and alcohol dependence and withdrawal. Neuropharmacology 1981;20:659-666.
27. Mäki T, Heikkonen E, Härkönen T, Kontula K, Härkönen M, Ylikahri R: Reduction of lymphocytic β-adrenoceptor level in chronic alcoholics and rapid reversal after ethanol withdrawal. Eur J Clin Invest 1990;20:313-316.
28. Mäki T, Kontula K, Härkönen T: The β-adrenergic system in man: Physiological and pathophysiological response. Regulation of receptor density and functioning. Scand J Clin Lab Invest Suppl 1990;201:25-43.
29. Murad F: Drugs used for the treatment of angina: Organic nitrates, calcium-channel blockers, and β-adrenergic antagonists; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990, pp 764-783.
30. Sandor P, Naranjo CA, Knouw V, Sellers EM: Variations in drug-free fraction during alcohol withdrawal. Br J Clin Pharmacol 1983;15:481-486.
31. McLean AJ, McNamara PJ, du Souich P, Gibaldi M, Lalka D: Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther 1978;24:5-10.
32. Piano MR, Ferguson JL, Melchior CL: Alterations in splanchnic blood flow following chronic ethanol exposure. Alcohol Clin Exp Res 1990;14:616-622.